Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4774697 | 0.81 | CASP3 (0.40) | CASP3ALDH1A1CA12CA9MEN1 | |
| SCHEMBL4017572 | 0.68 | ALDH1A1 (0.55) | CASP3ALDH1A1CA12CA9MEN1 | |
| SCHEMBL8431420 | 0.67 | CA12 (0.53) | CASP3ALDH1A1CA12CA9MEN1 | |
| SCHEMBL29740350 | 0.67 | CA12 (0.53) | CASP3ALDH1A1CA12CA9MEN1 | |
| SCHEMBL16654973 | 0.67 | ALDH1A1 (0.50) | CASP3ALDH1A1CA12CA9MAPT | |
| SCHEMBL16654972 | 0.67 | ALDH1A1 (0.50) | CASP3ALDH1A1CA12CA9MAPT | |
| SCHEMBL9386761 | 0.66 | ALDH1A1 (0.56) | ALDH1A1CA12CA9MEN1KMT2A | |
| SCHEMBL13873451 | 0.66 | ALDH1A1 (0.56) | ALDH1A1CA12CA9MEN1KMT2A | |
| SCHEMBL1969539 | 0.66 | CA12 (0.51) | CASP3ALDH1A1CA12CA9MEN1 | |
| SCHEMBL1969540 | 0.66 | CA12 (0.51) | CASP3ALDH1A1CA12CA9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060122404-A1 | Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of-alpha-perfluoroalkylamines | RHODIA CHIMIE (FR) | 2006-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122404-A1 | Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of-alpha-perfluoroalkylamines | PFAS, CYP2F1, SULT1A1 | CASP3 1332/4885ALDH1A1 367/4885CA12 2725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.